Could a 'Hibernation' drug protect the brain during stroke treatment?
NCT ID NCT07364344
Summary
This early-stage study is testing the safety of a two-drug combination (chlorpromazine and promethazine) given before a standard clot-removal procedure for stroke. The goal is to see if this 'hibernation-like' therapy is safe and might help reduce brain damage. The study will involve about 57 adults with moderate to severe strokes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.